AVITA Medical Inc. (RCEL)
NASDAQ: RCEL
· Real-Time Price · USD
5.54
0.07 (1.28%)
At close: Oct 03, 2025, 3:59 PM
5.47
-1.26%
After-hours: Oct 03, 2025, 06:52 PM EDT
AVITA Medical Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lease Revenue Revenue | 192K | 189K | 194K | 152K | 12K | 10.96M | 399K | 408K | 416K | 432K | 435K | 435K | 435K | 4.1M |
| Lease Revenue Revenue Growth | +1.59% | -2.58% | +27.63% | +1166.67% | -99.89% | +2647.37% | -2.21% | -1.92% | -3.70% | -0.69% | 0.00% | 0.00% | -89.39% | n/a |
| Recell System Revenue | 16.82M | 17.68M | n/a | 19.06M | 14.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Recell System Revenue Growth | -4.84% | n/a | n/a | +28.86% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia Revenue | 40K | 40K | 180K | 54K | 61K | 17K | 66K | 61K | 33K | 62K | 8.59M | 9M | 8.28M | 7.4M | 10.24M | 8.72M | 5.02M | 4.97M |
| Australia Revenue Growth | 0.00% | -77.78% | +233.33% | -11.48% | +258.82% | -74.24% | +8.20% | +84.85% | -46.77% | -99.28% | -4.57% | +8.67% | +11.90% | -27.75% | +17.36% | +73.80% | +1.01% | n/a |
| European Union Revenue | 49K | 49K | 1K | 388K | 103K | 51K | 1.06M | 581K | 708K | 1.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| European Union Revenue Growth | 0.00% | +4800.00% | -99.74% | +276.70% | +101.96% | -95.19% | +82.44% | -17.94% | -30.66% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Japan Revenue | 427K | 634K | 193K | 19.05M | 389K | 461K | 12.98M | 12.96M | 10.99M | 9.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Japan Revenue Growth | -32.65% | +228.50% | -98.99% | +4796.66% | -15.62% | -96.45% | +0.15% | +17.91% | +16.63% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 17.9M | 17.76M | 18M | n/a | 14.58M | 10.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +0.79% | -1.33% | n/a | n/a | +38.45% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 20.98M | 21.22M | 21.23M | 24.73M | 23.82M | 21.6M | 17.97M | 25.78M | 15.95M | 14.84M | 17.13M | 16.28M | 10.6M | 12.15M | 14.53M | 8.87M | 9.42M | 8.87M | 6.8M | 11.38M | 13.78M | 27.91M | 15.79M | 9.93M | 8.49M | 8.62M | 5.23M | 5.36M | 7.36M | 3.73M | 2.5M | 2.52M | 3.25M | 3.23M | 1.97M | 2.09M | 2.32M | 2.4M | 1.71M | 1.65M | 968.42K | 959.7K |
| Selling, General, and Administrative Revenue Growth | -1.15% | -0.04% | -14.15% | +3.83% | +10.27% | +20.24% | -30.31% | +61.62% | +7.52% | -13.41% | +5.21% | +53.68% | -12.83% | -16.36% | +63.89% | -5.88% | +6.18% | +30.39% | -40.20% | -17.43% | -50.61% | +76.74% | +58.94% | +17.01% | -1.53% | +64.97% | -2.54% | -27.16% | +97.27% | +49.08% | -0.50% | -22.47% | +0.60% | +63.84% | -5.73% | -10.11% | -3.07% | +40.27% | +3.59% | +70.35% | +0.91% | n/a |
| Research and Development Revenue | 5.12M | 6.28M | 4.85M | 5.43M | 4.89M | 5.19M | 6.76M | 6.84M | 7.62M | 6.86M | 4.96M | 5.94M | 4.43M | 4.84M | 5.78M | 3.39M | 3.97M | 5.41M | 4.36M | 4.71M | 3.68M | 4.06M | 3.3M | 2.42M | 1.55M | 1.42M | 2.49M | 2.56M | 275.78K | 2.9M | 1.97M | 1.98M | 1.44M | 1.43M | 908.23K | 963.39K | 711.07K | 733.59K | 563.96K | 544.42K | 1.09M | 1.08M |
| Research and Development Revenue Growth | -18.57% | +29.57% | -10.65% | +11.07% | -5.91% | -23.22% | -1.03% | -10.31% | +11.10% | +38.21% | -16.44% | +34.06% | -8.41% | -16.27% | +70.53% | -14.75% | -26.54% | +24.09% | -7.50% | +28.15% | -9.36% | +23.13% | +36.02% | +55.80% | +9.28% | -42.94% | -2.54% | +827.74% | -90.49% | +46.89% | -0.50% | +37.50% | +0.60% | +57.89% | -5.73% | +35.48% | -3.07% | +30.08% | +3.59% | -49.89% | +0.91% | n/a |
| Sales and Marketing Revenue | 14.31M | 14.83M | 14.11M | 15.14M | 16.3M | 12.64M | 10.22M | 16.38M | 9.79M | 6.54M | 9.32M | 8.46M | 5.33M | 4.83M | 6.82M | 3.52M | 4.15M | 3.65M | 3.6M | 3.27M | 4.26M | 7.11M | 5.66M | 4.39M | 3.96M | 3.67M | 2.44M | 2.5M | 528.79K | 2.35M | 1.1M | 1.1M | 1.29M | 1.29M | 662.14K | 702.35K | 726.07K | 749.06K | 550.85K | 531.76K | 741.68K | 735K |
| Sales and Marketing Revenue Growth | -3.51% | +5.14% | -6.83% | -7.10% | +28.97% | +23.73% | -37.64% | +67.30% | +49.74% | -29.80% | +10.11% | +58.67% | +10.44% | -29.19% | +93.81% | -15.15% | +13.62% | +1.36% | +10.26% | -23.36% | -40.12% | +25.67% | +28.99% | +10.76% | +8.07% | +50.19% | -2.54% | +373.68% | -77.51% | +114.01% | -0.50% | -14.66% | +0.60% | +94.22% | -5.73% | -3.27% | -3.07% | +35.98% | +3.59% | -28.30% | +0.91% | n/a |